COSCIENS Biopharma Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | 36.6% | -156.2% | -140.1% |
| FY2021 | 98.3% | -164.8% | -159.1% |
| FY2022 | 58.7% | 29.6% | 23.7% |
| FY2023 | 41.1% | -64.8% | -48.8% |
| FY2024 | 49.3% | -190.7% | -159.7% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | 36.6% | -156.2% | -140.1% |
| FY2021 | 98.3% | -164.8% | -159.1% |
| FY2022 | 58.7% | 29.6% | 23.7% |
| FY2023 | 41.1% | -64.8% | -48.8% |
| FY2024 | 49.3% | -190.7% | -159.7% |